A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)

Aminah Jatoi; Howard L. Ritter; Amylou C. Dueck; Phuong Nguyen; Daniel A. Nikcevich; Ronnie F. Luyun; Bassam Mattar; Charles L. Loprinzi

doi:10.1016/j.lungcan.2009.06.020

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)

著者: Aminah Jatoi, Howard L. Ritter, Amylou C. Dueck, Phuong Nguyen, Daniel A. Nikcevich, Ronnie F. Luyun, Bassam Mattar, Charles L. Loprinzi - Lung Cancer 2009 被引用: 218

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9) | Litlas